KLCM
GILD icon

KG&L Capital Management’s Gilead Sciences GILD Stock Holding History

KG&L Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,200
Closed -$15K – 100
2018
Q4 		$15K Buy
+1,200
New +$83.9K 0.02% 107

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

KG&L Capital Management's GILD Position: Q1 2021 in Review

KG&L Capital Management sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 4,842 shares — an estimated $282K sold.

KG&L Capital Management first reported a position in GILD in Q4 2018 and held it in 7 quarters. The position peaked at $914K in Q2 2019. 1,568 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • KG&L Capital Management reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • KG&L Capital Management sold 4,842 Gilead Sciences shares in Q1 2021, an estimated $282K.
  • KG&L Capital Management first reported a position in Gilead Sciences in Q4 2018 and held it in 7 quarters.
  • KG&L Capital Management's Gilead Sciences position peaked at $914K in Q2 2019.
  • 1,568 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on KG&L Capital Management's 13F filing for Q1 2021, filed 14 Apr 2021.